ClinicalTrials.Veeva

Menu

High Tea Consumption on Smoking Related Oxidative Stress

University of Arizona logo

University of Arizona

Status and phase

Completed
Phase 2

Conditions

Lung Cancer Prevention

Treatments

Dietary Supplement: Black tea
Dietary Supplement: Placebo tea
Dietary Supplement: Green tea

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT02719860
03-0014

Details and patient eligibility

About

The overall objective of this study is to determine the effect of high tea consumption on biological markers of oxidative stress that mediate lung cancer risk.

Enrollment

154 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • FEV1 < 85% and at least 25 pack-years of current or former smoking history.
  • No diagnosis of internal cancer within the last 5 years or no chemotherapy or radiation for an internal cancer within the last 5 years.
  • Meets the Southwest Oncology Group (SWOG) performance status criteria of 0-1.
  • Not be pregnant or intending to get pregnant during the study period (women participants).
  • Willing to drink 4 cups of tea (each cup will be brewed with 2 tea bags and 12 ounces of water) for 1-month run-in period and for the 6-month intervention period.
  • Willing to refrain from consuming other tea or tea products starting one month before the placebo run-in period and for the entire study period (a total of 8 months)
  • Willing to refrain from consuming more than one caffeinated product (coffee, soda..) starting one month before the placebo run-in period and for the entire study period (a total of 8 months).
  • Subjects cannot take mega-doses of vitamins during the trial. This is defined as more than 400 IU of vitamin E, 200 ug of selenium, or 1 gm of vitamin C per day, or more than the tolerable upper limits of any other supplement as defined in the Dietary Reference Intake panels developed by the Food and Nutrition Board under the Institute of Medicine. Such vitamin therapy must be discontinued at least 2 weeks prior to study entry.

Exclusion criteria

  • Subjects immunosuppressed by virtue of medication or disease.
  • Serious concurrent illness that could interfere with study regimen.
  • Subjects with a history of invasive cancer within the past 5 years.
  • Subjects who are drinking more than 5 cups of non-herbal tea per week.
  • Subjects who cannot or are unwilling to consume caffeinated beverages.
  • Subjects unable to perform forced expiratory maneuver during spirometry testing.
  • More than one acute emphysema exacerbation within the last 6 month -period .
  • Subjects on oxygen.
  • Women with positive urinary pregnancy test.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

154 participants in 3 patient groups, including a placebo group

Green tea
Experimental group
Treatment:
Dietary Supplement: Green tea
Black tea
Experimental group
Treatment:
Dietary Supplement: Black tea
Placebo tea
Placebo Comparator group
Treatment:
Dietary Supplement: Placebo tea

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems